BIOGEN INC. Share-based Payment Arrangement, Expense, Tax Benefit
BIOGEN INC. (BIIB) reported Share-based Payment Arrangement, Expense, Tax Benefit of $16.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-04-29
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $16.50M, a 3.13% increase year-over-year.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $11.70M, a 9.30% decline year-over-year.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $14.40M, a 40.50% decline year-over-year.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for the quarter ending 2025-06-30 was $14.90M, a 11.19% increase year-over-year.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for fiscal 2025 was $57.00M, a 10.09% decline from fiscal 2024.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for fiscal 2024 was $63.40M, a 52.19% decline from fiscal 2023.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for fiscal 2023 was $132.60M, a 169.51% increase from fiscal 2022.
- BIOGEN INC. share-based payment arrangement, expense, tax benefit for fiscal 2022 was $49.20M, a 5.35% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $16.50M 10-Q · filed 2026-04-29 | $28.20M derived: sum of 2 quarters · filed 2026-04-29 | $42.60M derived: sum of 3 quarters · filed 2026-04-29 | $57.50M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-12-31 | $11.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $26.10M derived: sum of 2 quarters · filed 2026-02-06 | $41.00M derived: sum of 3 quarters · filed 2026-02-06 | $57.00M 10-K · filed 2026-02-06 | |||
| 2025-09-30 | $14.40M 10-Q · filed 2025-10-30 | $29.30M derived: sum of 2 quarters · filed 2025-10-30 | $45.30M 10-Q · filed 2025-10-30 | $58.20M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-06-30 | $14.90M 10-Q · filed 2025-07-31 | $30.90M 10-Q · filed 2025-07-31 | $43.80M derived: sum of 3 quarters · filed 2026-04-29 | $68.00M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-03-31 | $16.00M 10-Q · filed 2026-04-29 | $28.90M derived: sum of 2 quarters · filed 2026-04-29 | $53.10M derived: sum of 3 quarters · filed 2026-04-29 | $66.50M derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $37.10M derived: sum of 2 quarters · filed 2026-02-06 | $50.50M derived: sum of 3 quarters · filed 2026-02-06 | $63.40M 10-K · filed 2026-02-06 | |||
| 2024-09-30 | $24.20M 10-Q · filed 2025-10-30 | $37.60M derived: sum of 2 quarters · filed 2025-10-30 | $50.50M 10-Q · filed 2025-10-30 | $56.60M derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2024-06-30 | $13.40M 10-Q · filed 2025-07-31 | $26.30M 10-Q · filed 2025-07-31 | $32.40M derived: sum of 3 quarters · filed 2026-02-06 | $130.90M derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2024-03-31 | $12.90M 10-Q · filed 2025-05-01 | $19.00M derived: sum of 2 quarters · filed 2026-02-06 | $117.50M derived: sum of 3 quarters · filed 2026-02-06 | $130.80M derived: sum of 4 quarters · filed 2026-02-06 | |||
| 2023-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $104.60M derived: sum of 2 quarters · filed 2026-02-06 | $117.90M derived: sum of 3 quarters · filed 2026-02-06 | $132.60M 10-K · filed 2026-02-06 | |||
| 2023-09-30 | $98.50M 10-Q · filed 2024-10-30 | $111.80M derived: sum of 2 quarters · filed 2024-10-30 | $126.50M 10-Q · filed 2024-10-30 | $139.70M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-06-30 | $13.30M 10-Q · filed 2024-08-01 | $28.00M 10-Q · filed 2024-08-01 | $41.20M derived: sum of 3 quarters · filed 2025-02-12 | $54.20M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-03-31 | $14.70M 10-Q · filed 2024-04-24 | $27.90M derived: sum of 2 quarters · filed 2025-02-12 | $40.90M derived: sum of 3 quarters · filed 2025-02-12 | $51.10M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | $13.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $26.20M derived: sum of 2 quarters · filed 2025-02-12 | $36.40M derived: sum of 3 quarters · filed 2025-02-12 | $49.20M 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $13.00M 10-Q · filed 2023-11-08 | $23.20M derived: sum of 2 quarters · filed 2023-11-08 | $36.00M 10-Q · filed 2023-11-08 | $46.90M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-06-30 | $10.20M 10-Q · filed 2023-07-25 | $23.00M 10-Q · filed 2023-07-25 | $33.90M derived: sum of 3 quarters · filed 2024-02-14 | $44.80M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2022-03-31 | $12.80M 10-Q · filed 2023-04-25 | $23.70M derived: sum of 2 quarters · filed 2024-02-14 | $34.60M derived: sum of 3 quarters · filed 2024-02-14 | $45.50M derived: sum of 4 quarters · filed 2024-02-14 | |||
| 2021-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $21.80M derived: sum of 2 quarters · filed 2024-02-14 | $32.70M derived: sum of 3 quarters · filed 2024-02-14 | $46.70M 10-K · filed 2024-02-14 | |||
| 2021-09-30 | $10.90M 10-Q · filed 2022-10-25 | $21.80M derived: sum of 2 quarters · filed 2022-10-25 | $35.80M 10-Q · filed 2022-10-25 | $43.60M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2021-06-30 | $10.90M 10-Q · filed 2022-07-20 | $24.90M 10-Q · filed 2022-07-20 | $32.70M derived: sum of 3 quarters · filed 2023-02-15 | $38.10M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2021-03-31 | $14.00M 10-Q · filed 2022-05-03 | $21.80M derived: sum of 2 quarters · filed 2023-02-15 | $27.20M derived: sum of 3 quarters · filed 2023-02-15 | $34.20M derived: sum of 4 quarters · filed 2023-02-15 | |||
| 2020-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $13.20M derived: sum of 2 quarters · filed 2023-02-15 | $20.20M derived: sum of 3 quarters · filed 2023-02-15 | $33.50M 10-K · filed 2023-02-15 | |||
| 2020-09-30 | $5.40M 10-Q · filed 2021-10-20 | $12.40M derived: sum of 2 quarters · filed 2021-10-20 | $25.70M 10-Q · filed 2021-10-20 | $32.30M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-06-30 | $7.00M 10-Q · filed 2021-07-22 | $20.30M 10-Q · filed 2021-07-22 | $26.90M derived: sum of 3 quarters · filed 2022-02-03 | $35.00M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2020-03-31 | $13.30M 10-Q · filed 2021-04-22 | $19.90M derived: sum of 2 quarters · filed 2022-02-03 | $28.00M derived: sum of 3 quarters · filed 2022-02-03 | $41.60M derived: sum of 4 quarters · filed 2022-02-03 | |||
| 2019-12-31 | $6.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $14.70M derived: sum of 2 quarters · filed 2022-02-03 | $28.30M derived: sum of 3 quarters · filed 2022-02-03 | $35.70M 10-K · filed 2022-02-03 | |||
| 2019-09-30 | $8.10M 10-Q · filed 2020-10-21 | $21.70M derived: sum of 2 quarters · filed 2020-10-21 | $29.10M 10-Q · filed 2020-10-21 | $34.80M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-06-30 | $13.60M 10-Q · filed 2020-07-22 | $21.00M 10-Q · filed 2020-07-22 | $26.70M derived: sum of 3 quarters · filed 2021-02-03 | $34.40M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2019-03-31 | $7.40M 10-Q · filed 2020-04-23 | $13.10M derived: sum of 2 quarters · filed 2021-02-03 | $20.80M derived: sum of 3 quarters · filed 2021-02-03 | $27.30M derived: sum of 4 quarters · filed 2021-02-03 | |||
| 2018-12-31 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $13.40M derived: sum of 2 quarters · filed 2021-02-03 | $19.90M derived: sum of 3 quarters · filed 2021-02-03 | $27.50M 10-K · filed 2021-02-03 | |||
| 2018-09-30 | $7.70M 10-Q · filed 2019-10-22 | $14.20M derived: sum of 2 quarters · filed 2019-10-22 | $21.80M 10-Q · filed 2019-10-22 | $32.80M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-06-30 | $6.50M 10-Q · filed 2019-07-24 | $14.10M 10-Q · filed 2019-07-24 | $25.10M derived: sum of 3 quarters · filed 2020-02-06 | $36.00M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2018-03-31 | $7.60M 10-Q · filed 2019-04-24 | $18.60M derived: sum of 2 quarters · filed 2020-02-06 | $29.50M derived: sum of 3 quarters · filed 2020-02-06 | $38.00M derived: sum of 4 quarters · filed 2020-02-06 | |||
| 2017-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $21.90M derived: sum of 2 quarters · filed 2020-02-06 | $30.40M derived: sum of 3 quarters · filed 2020-02-06 | $42.80M 10-K · filed 2020-02-06 | |||
| 2017-09-30 | $10.90M 10-Q · filed 2018-10-23 | $19.40M derived: sum of 2 quarters · filed 2018-10-23 | $31.80M 10-Q · filed 2018-10-23 | $43.30M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-06-30 | $8.50M 10-Q · filed 2018-07-24 | $20.90M 10-Q · filed 2018-07-24 | $32.40M derived: sum of 3 quarters · filed 2019-02-06 | $47.00M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2017-03-31 | $12.40M 10-Q · filed 2018-04-24 | $23.90M derived: sum of 2 quarters · filed 2019-02-06 | $38.50M derived: sum of 3 quarters · filed 2019-02-06 | $51.20M derived: sum of 4 quarters · filed 2019-02-06 | |||
| 2016-12-31 | $11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $26.10M derived: sum of 2 quarters · filed 2019-02-06 | $38.80M derived: sum of 3 quarters · filed 2019-02-06 | $54.00M 10-K · filed 2019-02-06 | |||
| 2016-09-30 | $14.60M 10-Q · filed 2017-10-24 | $27.30M derived: sum of 2 quarters · filed 2017-10-24 | $42.50M 10-Q · filed 2017-10-24 | $52.30M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-06-30 | $12.70M 10-Q · filed 2017-07-25 | $27.90M 10-Q · filed 2017-07-25 | $37.70M derived: sum of 3 quarters · filed 2018-02-01 | $44.10M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2016-03-31 | $15.20M 10-Q · filed 2017-04-25 | $25.00M derived: sum of 2 quarters · filed 2018-02-01 | $31.40M derived: sum of 3 quarters · filed 2018-02-01 | $44.30M derived: sum of 4 quarters · filed 2018-02-01 | |||
| 2015-12-31 | $9.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $16.20M derived: sum of 2 quarters · filed 2018-02-01 | $29.10M derived: sum of 3 quarters · filed 2018-02-01 | $55.80M 10-K · filed 2018-02-01 | |||
| 2015-09-30 | $6.40M 10-Q · filed 2016-10-26 | $19.30M derived: sum of 2 quarters · filed 2016-10-26 | $46.00M 10-Q · filed 2016-10-26 | $62.80M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-06-30 | $12.90M 10-Q · filed 2016-07-21 | $39.60M 10-Q · filed 2016-07-21 | $56.40M derived: sum of 3 quarters · filed 2017-02-02 | $73.00M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2015-03-31 | $26.70M 10-Q · filed 2016-04-21 | $43.50M derived: sum of 2 quarters · filed 2017-02-02 | $60.10M derived: sum of 3 quarters · filed 2017-02-02 | $76.60M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $33.40M derived: sum of 2 quarters · filed 2017-02-02 | $49.90M derived: sum of 3 quarters · filed 2017-02-02 | $72.20M 10-K · filed 2017-02-02 | |||
| 2014-09-30 | $16.60M 10-Q · filed 2015-10-21 | $33.10M derived: sum of 2 quarters · filed 2015-10-21 | $55.40M 10-Q · filed 2015-10-21 | $74.40M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-06-30 | $16.50M 10-Q · filed 2015-07-24 | $38.80M 10-Q · filed 2015-07-24 | $57.80M derived: sum of 3 quarters · filed 2016-02-03 | $75.20M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2014-03-31 | $22.30M 10-Q · filed 2015-04-24 | $41.30M derived: sum of 2 quarters · filed 2016-02-03 | $58.70M derived: sum of 3 quarters · filed 2016-02-03 | $79.00M derived: sum of 4 quarters · filed 2016-02-03 | |||
| 2013-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $36.40M derived: sum of 2 quarters · filed 2016-02-03 | $56.70M derived: sum of 3 quarters · filed 2016-02-03 | $73.30M 10-K · filed 2016-02-03 | |||
| 2013-09-30 | $17.40M 10-Q · filed 2014-10-22 | $37.70M derived: sum of 2 quarters · filed 2014-10-22 | $54.30M 10-Q · filed 2014-10-22 | $67.60M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-06-30 | $20.30M 10-Q · filed 2014-07-23 | $36.90M 10-Q · filed 2014-07-23 | $50.20M derived: sum of 3 quarters · filed 2015-02-04 | $63.20M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2013-03-31 | $16.60M 10-Q · filed 2014-04-23 | $29.90M derived: sum of 2 quarters · filed 2015-02-04 | $42.90M derived: sum of 3 quarters · filed 2015-02-04 | $55.60M derived: sum of 4 quarters · filed 2015-02-04 | |||
| 2012-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $26.30M derived: sum of 2 quarters · filed 2015-02-04 | $39.00M derived: sum of 3 quarters · filed 2015-02-04 | $53.40M 10-K · filed 2015-02-04 | |||
| 2012-09-30 | $13.00M 10-Q · filed 2013-10-28 | $25.70M derived: sum of 2 quarters · filed 2013-10-28 | $40.10M 10-Q · filed 2013-10-28 | $51.70M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-06-30 | $12.70M 10-Q · filed 2013-07-25 | $27.10M 10-Q · filed 2013-07-25 | $38.70M derived: sum of 3 quarters · filed 2014-02-06 | $48.70M derived: sum of 4 quarters · filed 2014-02-06 | |||
| 2012-03-31 | $14.40M 10-Q · filed 2013-04-25 | -$14.40M 10-Q · filed 2012-05-01 | $26.00M derived: sum of 2 quarters · filed 2014-02-06 | $36.00M derived: sum of 3 quarters · filed 2014-02-06 | $46.90M derived: sum of 4 quarters · filed 2014-02-06 | ||
| 2011-12-31 | $11.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $21.60M derived: sum of 2 quarters · filed 2014-02-06 | $32.50M derived: sum of 3 quarters · filed 2014-02-06 | $44.60M 10-K · filed 2014-02-06 | -$44.60M 10-K · filed 2012-02-03 | ||
| 2011-09-30 | $10.00M 10-Q · filed 2012-10-25 | -$10.00M 10-Q · filed 2011-10-28 | $20.90M derived: sum of 2 quarters · filed 2012-10-25 | $33.00M 10-Q · filed 2012-10-25 | -$33.00M 10-Q · filed 2011-10-28 | $114.60M derived: sum of 4 quarters · filed 2013-02-05 | |
| 2011-06-30 | $10.90M 10-Q · filed 2012-07-24 | $23.00M 10-Q · filed 2012-07-24 | $104.60M derived: sum of 3 quarters · filed 2013-02-05 | $91.60M derived: sum of 4 quarters · filed 2013-02-05 | |||
| 2011-03-31 | -$12.00M 10-Q · filed 2012-05-01 | $93.70M derived: sum of 2 quarters · filed 2013-02-05 | $80.70M derived: sum of 3 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $105.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $92.70M derived: sum of 2 quarters · filed 2013-02-05 | $60.30M 10-K · filed 2013-02-05 | -$60.30M 10-K · filed 2012-02-03 | |||
| 2010-09-30 | -$13.00M 10-Q · filed 2011-10-28 | -$45.40M 10-Q · filed 2011-10-28 | |||||
| 2009-12-31 | -$49.40M 10-K · filed 2012-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |